Milestone 5 definition

Milestone 5 means the achievement of worldwide aggregate Net Sales of the Product (inclusive of all Indications) of at least two hundred fifty million U.S. dollars ($250,000,000), calculated on a cumulative basis for all Calendar Years (or portion thereof), provided that Milestone 3 is achieved by or before December 31, 2030.
View Source
Milestone 5 means FDA approval of a NDA for FX301.
View Source
Milestone 5 has the meaning provided in the Project Agreement.
View Source

Examples of Milestone 5 in a sentence

  • If Milestone 5 has not occurred on or before April 30, 2026 (the “Milestone 5 Deadline”), Borrower shall have no right to receive any portion of the Tranche 5 Loan, unless otherwise agreed in writing by ▇▇▇▇▇▇.

  • Upon receiving the Milestone 5 Notice, the Lenders shall pay to Borrower an amount equal to the Tranche 5 Draw Amount by wire transfer of immediately available funds to the account specified in such notice within three Business Days following receipt thereof.

  • Within three Business Days following the Milestone 5 Deadline, Borrower shall provide a written notice to Lender, in the form attached hereto as Exhibit A (the “Milestone 5 Notice”) stating the amount, if any, to be drawn by Borrower from the Tranche 5 Loan pursuant to this Section 2(a)(v) (the “Tranche 5 Draw Amount” and, together with the Tranche 1 Draw Amount, the Tranche 2 Draw Amount, the Tranche 3 Draw Amount and the Tranche 4 Draw Amount, the “Draw Amounts”).

  • The warrants shall expire upon the earlier of (i) sixty (60) days following the achievement of Milestone 5 or (ii) September 30, 2026, and will be exercisable by the Lender at any time, subject to the restrictions in Section 10; provided that, the foregoing notwithstanding, the Warrants shall not expire until at least sixty (60) days after shareholder approval of this Note and the Warrants has been obtained as contemplated by Section 10(g) below.


More Definitions of Milestone 5

Milestone 5. [ ]* [ ]* Milestone 6: [ ]* [ ]*. Each milestone is independent, so that the achievement of any one milestone with respect to a Research Compound or Product does not require payment of lower numbered unachieved milestones with respect to that Compound or Product.
View Source
Milestone 5 means cumulative Net Sales of the Product Candidate exceeding three hundred million dollars ($300,000,000), inclusive of Milestone #4, but only if the foregoing Milestone is achieved no later than the Milestone Target Date.
View Source
Milestone 5. Clinical Trial Assay Build Completion (Including CTA QC and Control Specifications) This milestone entails activities required to complete development of the Clinical Trial Assay for use in Phase III Clinical Trial. The assay is planned to be presented to CDRH under an Investigational Device Exemption application. The following work packages will be competed; [**].
View Source
Milestone 5. CubeRover EM Integrated with Cable Reel Target Date: ATP + 10.5 Months Entrance Criteria: 1. CubeRover, Cable, and Reel Engineering Model Integration and Test Plan has been drafted. 2. CubeRover, Cable, and Reel Master Build Reports are complete. Success Criteria: 1. CubeRover, Cable, and Reel Engineering Model Integration and Test report uploaded to NASA server. 2. CubeRover, Cable, and Reel Engineering Model Integration and Test report reflects the as assembled & integrated CubeRover EM / Cable and Reel EM.
View Source
Milestone 5. Program/Project 2 Sub Application Title 2: Scope of Work 2: Program/Project Matrix Code 2: Program/Project’s National Objective 2: Sub Award Number: Milestones:
View Source
Milestone 5. If the Consumer Business Unit records $75 million in revenue for calendar 2023, the CVR Payment Amount for this Milestone will be $2,500,000 (as such amount may be adjusted pursuant to the Riders below). If the Consumer Business Unit achieves profitability from operations for calendar 2023, then the CVR Payment Amount for this Milestone will be increased by $2,500,000 (as such amount may be adjusted pursuant to the Riders below).
View Source
Milestone 5. For New South Wales, Victoria and South Australia only, the State has provided a brief description of supply measure projects for which feasibility and business cases are being developed for consideration under the SDL adjustment mechanism
View Source